Faculty Opinions recommendation of A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718113892.793485442 ◽

2013 ◽

Author(s):

Luca Persani

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase ◽

Histologic Subtypes ◽

Metastatic Thyroid Cancer

Download Full-text

A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes

Annals of Oncology ◽

10.1093/annonc/mdt379 ◽

2013 ◽

Vol 24 (12) ◽

pp. 3089-3094 ◽

Author(s):

S.M. Lim ◽

H. Chang ◽

M.J. Yoon ◽

Y.K. Hong ◽

H. Kim ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase ◽

Histologic Subtypes ◽

Metastatic Thyroid Cancer

Download Full-text

Faculty of 1000 evaluation for A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718113892.793485225 ◽

2013 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase ◽

Histologic Subtypes ◽

Metastatic Thyroid Cancer

Download Full-text

Faculty of 1000 evaluation for A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718113892.793486323 ◽

2013 ◽

Author(s):

Mario Salvi

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase ◽

Histologic Subtypes ◽

Metastatic Thyroid Cancer

Download Full-text

Faculty of 1000 evaluation for A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718113892.793485355 ◽

2013 ◽

Author(s):

Ulla Feldt-Rasmussen

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase ◽

Histologic Subtypes ◽

Metastatic Thyroid Cancer

Download Full-text

Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter Phase II Trial

Thyroid ◽

10.1089/thy.2020.0235 ◽

2020 ◽

Author(s):

Yan-Song Lin ◽

Hui Yang ◽

Yong Ding ◽

Yi-Zhuang Cheng ◽

Feng Shi ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Radioactive Iodine ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase

Download Full-text

265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.259 ◽

2020 ◽

Vol 31 ◽

pp. S1347

Author(s):

Y. Chi ◽

M. Gao ◽

Y. Zhang ◽

F. Shi ◽

Y. Cheng ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Differentiated Thyroid Carcinoma ◽

Double Blind ◽

Multicenter Phase

Download Full-text

229TiP A single arm, open-label, multicenter, phase II trial of oxaliplatin plus capecitabine (XELOX) in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC)

Annals of Oncology ◽

10.1093/annonc/mdv523.90 ◽

2015 ◽

Vol 26 ◽

pp. ix42

Author(s):

T. Liu ◽

Y. Yu ◽

Y. Sun ◽

M. Yan ◽

H. Cao ◽

...

Keyword(s):

Gastric Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Perioperative Treatment ◽

D2 Gastrectomy ◽

Multicenter Phase ◽

Advanced Gastric Adenocarcinoma

Download Full-text

Prospective Feasible Study to Evaluate Neoadjuvant-Synchronus S-1 + RT for Locally Advanced Rectal Cancer: A Multicenter Phase-II Trial (UMIN ID03396)

Annals of Oncology ◽

10.1016/s0923-7534(20)33230-0 ◽

2012 ◽

Vol 23 ◽

pp. ix208

Author(s):

M. Inomata

Keyword(s):

Rectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Locally Advanced Rectal Cancer ◽

Multicenter Phase ◽

Download Full-text

A single arm, multicenter, phase II trial of everolimus as monotherapy in the palliative treatment of patients with locally advanced or metastatic transitional cell carcinoma after failure of platinum-based chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e15087 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e15087-e15087 ◽

Author(s):

E. Seront ◽

S. Rottey ◽

B. Sautois ◽

L. A. D'Hondt ◽

J. R. Canon ◽

...

Keyword(s):

Transitional Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Palliative Treatment ◽

Phase Ii Trial ◽

Locally Advanced ◽

Transitional Cell ◽

Multicenter Phase ◽

Platinum Based Chemotherapy

Download Full-text

Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4544 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4544-4544 ◽

Author(s):

A. Font ◽

E. Esteban ◽

J. Carles ◽

M. A. Climent ◽

J. L. Gonzalez-Larriba ◽

...

Keyword(s):

Phase Ii ◽

Urothelial Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase ◽

Metastatic Urothelial Cancer ◽

Download Full-text